In 2000 he was President of American Society of Microbiology and also became President of the International Union of Microbiological Societies. In 1997 he founded the West-East Centre for research on antibiotic discovery and this was morphed into TerraGen Diversity (acquired by Cubist Pharmaceuticals in 2000). He joined UBC as Professor and Head of M&I in 1992. He left 1986 to become Director of the Microbial Engineering Unit at the Institute Pasteur. In 1980 he became as Scientific Director of the Geneva operation biotech company Biogen. In 1967 as Associate Professor and subsequently Professor. He joined the Biochemistry Department at the University of Wisconsin, Madison. In 1962 he switched to microbiology at Harvard Medical School followed by two years at the Institute Pasteur in Paris. After postdoctoral fellowships at Columbia University and the University of Wisconsin he taught at the University of Manchester Institute of Technology. where he received a BSc (1953) and PhD (1956) in Chemistry. Davies was born in Neath, South Wales in 1932 and attended the University of Nottingham, U.K. Davies has also contributed to studies of the origins and evolution of antibiotic resistance genes. In particular he has proposed that antibiotics serve two functions: as signaling agents in nature and as therapeutic agents in clinical practice. He is a microbiologist recognized for his work on the mode of action of antibiotics and the mechanisms of antibiotic resistance. Julian Davies is an active Professor Emeritus in the Department of Microbiology and Immunology (M&I) at the University of British Columbia in Vancouver.
Committee on International Security and Arms Control.Policy on Discrimination, Harassment, and Bullying.
0 kommentar(er)
